We are live on
!
Find out more
EP
Evelyn Partners Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
551
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
PJT Partners
PJT
$4.46B
| $11.8K | ﹤0.01% |
+78
| New | +$12K |
|
477
Check Point Software Technologies
CHKP
$13.4B
| $11.3K | ﹤0.01% |
+86
| New | +$11.2K |
|
478
Fortive
FTV
$18.6B
| $11.2K | ﹤0.01% |
+183
| New | +$11K |
|
479
Nordic American Tanker
NAT
$1.42B
| $11.1K | ﹤0.01% |
+2,000
| New | +$11.3K |
|
480
Denison Mines
DNN
$2.92B
| $10.9K | ﹤0.01% |
+3,563
| New | +$12.4K |
|
481
Church & Dwight Co
CHD
$24B
| $10.6K | ﹤0.01% |
+109
| New | +$10.4K |
|
482
Petrobras
PBR
$115B
| $10.5K | ﹤0.01% |
+650
| New | +$12.7K |
|
483
Enphase Energy
ENPH
$5.35B
| $10.2K | ﹤0.01% |
+207
| New | +$9.43K |
|
484
Carnival Corporation Ltd
CCL
$38.5B
| $9.51K | ﹤0.01% |
+333
| New | +$9.1K |
|
485
Haleon
HLN
$42.7B
| $9.06K | ﹤0.01% |
+971
| New | +$9.03K |
|
|
VSNT
486
Versant Media Group
VSNT
$5.52B
| $9.04K | ﹤0.01% |
+251
| New | +$10.1K |
|
487
O'Reilly Automotive
ORLY
$73.7B
| $8.29K | ﹤0.01% |
+90
| New | +$8.21K |
|
488
Pacer Trendpilot US Bond ETF
PTBD
$86.2M
| $7.97K | ﹤0.01% |
+416
| New | +$7.98K |
|
489
Bio-Rad Laboratories Class A
BIO
$9.53B
| $7.93K | ﹤0.01% |
+27
| New | +$7.66K |
|
490
Clearfield
CLFD
$391M
| $7.72K | ﹤0.01% |
+194
| New | +$7.11K |
|
491
Vanguard ESG US Stock ETF
ESGV
$13.7B
| $7.41K | ﹤0.01% |
+56
| New | +$7.14K |
|
492
Trane Technologies
TT
$106B
| $7.37K | ﹤0.01% |
+15
| New | +$7.01K |
|
493
Albemarle
ALB
$16.1B
| $7.16K | ﹤0.01% |
+53
| New | +$9.35K |
|
494
Zimmer Biomet
ZBH
$19.2B
| $6.89K | ﹤0.01% |
+80
| New | +$7.01K |
|
495
Invesco Global Clean Energy ETF
PBD
$195M
| $6.78K | ﹤0.01% |
+346
| New | +$7.07K |
|
496
Kinder Morgan
KMI
$73.1B
| $6.68K | ﹤0.01% |
+209
| New | +$6.74K |
|
497
Global Payments
GPN
$24.6B
| $6.68K | ﹤0.01% |
+92
| New | +$6.33K |
|
498
SELLAS Life Sciences
SLS
$2.58B
| $6.64K | ﹤0.01% |
+450
| New | +$3.11K |
|
499
iShares MSCI Germany ETF
EWG
$1.68B
| $6.21K | ﹤0.01% |
+150
| New | +$6.31K |
|
500
Baidu
BIDU
$35.2B
| $6.17K | ﹤0.01% |
+54
| New | +$6.69K |
|
Similar funds
SCP
Evelyn Partners's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.